Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB056A | — |
powder portion was drowning up with normal saline; powder portion was drowning up with normal saline; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB056A, expiry date 31-AUG-2025) for prophylaxis. On 01-APR-2025, the patient received Menveo. On 01-APR-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: powder portion was drowning up with normal saline) and inappropriate dose of vaccine administered (Verbatim: powder portion was drowning up with normal saline). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 07-APR-2025 Other HCP reported that they received a box with 2 vials presentation (Menveo), one the powder one the liquid, and when drowning up to give to a patient, powder portion was drowning up with normal saline and the liquid was completely not given. Menveo reconstituted with normal saline instead of the supplied CYW-135 liquid conjugate, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.